JULIA ELLINGWOOD: Open Payments
NPI 1790199255 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,047 in 114 payments from 30 companies in 2025. Trend: 2023 $2,247 · 2024 $2,013 · 2025 $2,047
Food & beverage: $2,047
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $249 |
| Lilly USA, LLC | 17 | $215 |
| Abbott Laboratories | 13 | $194 |
| Medtronic, Inc. | 9 | $165 |
| BETA BIONICS, INC. | 4 | $103 |
| Corcept Therapeutics | 5 | $96 |
| Insulet Corporation | 4 | $90 |
| Tandem Diabetes Care, Inc. | 6 | $87 |
| Neurocrine BioSciences, Inc. | 2 | $75 |
| Dexcom, Inc. | 3 | $68 |
Products named: FREESTYLE LIBRE 3, INPEN SMART INSULIN DELIVERY SYSTEM, RINVOQ, MOUNJARO, iLet Bionic Pancreas, Korlym, Omnipod, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across IN — which companies pay providers there.
